|
Journal of Lipid Research, Vol 31, 1109-1120, Copyright © 1990 by Lipid Research, Inc.
A cross-species comparison of the apolipoprotein B domain that binds to the LDL receptor
A Law and J Scott
Division of Molecular Medicine, Clinical Research Centre, Harrow, Middlesex, UK.
Apolipoprotein (apo)-B-100 is the ligand that mediates the clearance of low
density lipoprotein (LDL) from the circulation by the apoB,E (LDL) receptor
pathway. Clearance is mediated by the interaction of a domain enriched in
basic amino acid residues on apoB-100 with clusters of acidic residues on
the apoB,E (LDL) receptor. A model has been proposed for the LDL receptor
binding domain of apoB-100 based on the primary amino acid sequence (Knott,
T. J., et al. 1986. Nature. 323: 734-738). Two clusters of basic residues
(A: 3147-3157 and B: 3359-3367) are apposed on the surface of the LDL
particle by a disulfide bridge between Cys 3167 and 3297. Support for this
single domain model has been obtained from the mapping of epitopes for
anti-apoB monoclonal antibodies that block the binding of apoB to the LDL
receptor. Here we test this model by comparing the nucleotide (from 9623 to
10,442) and amino acid sequence (from 3139 to 3411) of apoB-100 in seven
species (human, pig, rabbit, rat, Syrian hamster, mouse, and chicken).
Overall, this region is highly conserved. Cluster B maintains a strong net
positive charge and is homologous across species in both primary and
secondary structure. However, the net positive charge of region A is not
conserved across these species, but the region remains strongly
hydrophilic. The secondary structure of the region between clusters A and B
is preserved, but the disulfide bond is unique to the human sequence. This
study suggests that the basic region B is primarily involved in the binding
of apoB-100 to the apoB,E (LDL) receptor.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Zheng, J. Chen, H. Li, and J. D. Glickson
Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents
PNAS,
December 6, 2005;
102(49):
17757 - 17762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Flood, M. Gustafsson, R. E. Pitas, L. Arnaboldi, R. L. Walzem, and J. Boren
Molecular Mechanism for Changes in Proteoglycan Binding on Compositional Changes of the Core and the Surface of Low-Density Lipoprotein-Containing Human Apolipoprotein B100
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2004;
24(3):
564 - 570.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. P. Segrest, M. K. Jones, H. De Loof, and N. Dashti
Structure of apolipoprotein B-100 in low density lipoproteins
J. Lipid Res.,
September 1, 2001;
42(9):
1346 - 1367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fisher, H. Scharnagl, M. M. Hoffmann, K. Kusterer, D. Wittmann, H. Wieland, W. Gross, and W. Marz
Mutations in the Apolipoprotein (apo) B-100 Receptor-binding region: Detection of apo B-100 (Arg3500->Trp) Associated with Two New Haplotypes and Evidence That apo B-100 (Glu3405->Gln) Diminishes Receptor-mediated Uptake of LDL
Clin. Chem.,
July 1, 1999;
45(7):
1026 - 1038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Olsson, G. Camejo, E. Hurt-Camejo, K. Elfsber, O. Wiklund, and G. Bondjers
Possible Functional Interactions of Apolipoprotein B-100 Segments That Associate With Cell Proteoglycans and the ApoB/E Receptor
Arterioscler. Thromb. Vasc. Biol.,
January 1, 1997;
17(1):
149 - 155.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Sivaram, T. Vanni-Reyes, and I. J. Goldberg
Endothelial Cells Synthesize and Process Apolipoprotein B
J. Biol. Chem.,
June 21, 1996;
271(25):
15261 - 15266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. N. Trieu and W. J. McConathy
A Two-step Model for Lipoprotein(a) Formation
J. Biol. Chem.,
June 30, 1995;
270(26):
15471 - 15474.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|